Aurinia Pharmaceuticals (AUPH) Capital Expenditures (QoQ) (2020 - 2025)
Aurinia Pharmaceuticals (AUPH) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -4,494.12% |
| Mar 31, 2025 | 139.53% |
| Dec 31, 2024 | 66.41% |
| Sep 30, 2024 | -200.00% |
| Jun 30, 2024 | 966.67% |
| Mar 31, 2024 | 102.98% |
| Dec 31, 2023 | -283.81% |
| Sep 30, 2023 | -120.71% |
| Jun 30, 2023 | 2,882.35% |
| Mar 31, 2023 | -91.71% |
| Dec 31, 2022 | 412.50% |
| Sep 30, 2022 | 2.56% |
| Jun 30, 2022 | -50.63% |
| Mar 31, 2022 | 105.09% |
| Dec 31, 2021 | -144.31% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 1,628.38% |
| Mar 31, 2021 | 94.41% |
| Dec 31, 2020 | -210.08% |
| Sep 30, 2020 | 1,156.76% |